Our Team

Thierry Laugel

Strategic Advisor

Thierry Laugel is Chairman of the executive board of Kurma Partners. He is a qualified pharmacist with a PhD in pharmacology and an MBA from INSEAD.

After completing his doctoral thesis, Thierry spent four years with Laboratoires Fournier as a scientific representative in Japan, at the time when Lipanthyl was registered in Japan and research programs were being set up with Grelan (Takeda group). After studying at INSEAD, he joined Flamel Technologies as project director in pharmaceutical R&D following the company's IPO on the Nasdaq.

In 1998, he moved into the investment world, first at Caisse des Dépôts (CDC Innovation, then within the PharmaVent project) and then at AGF Private Equity, where he oversaw the healthcare investment team.